183 related articles for article (PubMed ID: 23009111)
1. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.
Huang WT; Weng SW; Huang CC; Lin HC; Tsai PC; Chuang JH
APMIS; 2012 Nov; 120(11):872-81. PubMed ID: 23009111
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
5. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9.
Zhang Y; Lin A; Zhang C; Tian Z; Zhang J
Cancer Immunol Immunother; 2014 Apr; 63(4):357-67. PubMed ID: 24452201
[TBL] [Abstract][Full Text] [Related]
7. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
Assaf A; Esteves H; Curnow SJ; Browning MJ
Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
[TBL] [Abstract][Full Text] [Related]
8. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
[TBL] [Abstract][Full Text] [Related]
9. An oligodeoxynucleotide with CCT repeats restrains CpG ODN-induced TLR9 trafficking.
Zhang X; Sun W; Wu X; Wang H; Yan Y; Guo S; Song D; Li H; Gao S; Wang L; Yu Y; Wang L
Curr Pharm Biotechnol; 2014; 15(9):780-9. PubMed ID: 25374030
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways.
Qi XF; Zheng L; Kim CS; Lee KJ; Kim DH; Cai DQ; Qin JW; Yu YH; Wu Z; Kim SK
Mol Immunol; 2013 Jul; 54(3-4):327-37. PubMed ID: 23357786
[TBL] [Abstract][Full Text] [Related]
12. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways.
Chen W; Wang J; An H; Zhou J; Zhang L; Cao X
Immunol Lett; 2005 Apr; 98(1):153-9. PubMed ID: 15790521
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
[TBL] [Abstract][Full Text] [Related]
15. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
16. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
17. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
Natarajan S; Ranganathan M
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
[TBL] [Abstract][Full Text] [Related]
19. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
[TBL] [Abstract][Full Text] [Related]
20. A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
Kubarenko AV; Ranjan S; Rautanen A; Mills TC; Wong S; Vannberg F; Neumaier M; Bekeredjian-Ding I; Hill AV; Ahmad-Nejad P; Weber AN
J Biol Chem; 2010 Nov; 285(47):36486-94. PubMed ID: 20843814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
